HYE SUN LEE: Open Payments
NPI 1598266355 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 28 payments from 10 companies in 2025. Trend: 2023 $668 · 2024 $962 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $147 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| ABBVIE INC. | 5 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| PFIZER INC. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Corcept Therapeutics | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Wegovy, FARXIGA, QULIPTA, XIFAXAN, Veozah, UBRELVY, Korlym, SPRAVATO.
Industry payments across GA — which companies pay providers there.
